Lab-on-a-chip for oral cancer screening and diagnosis

Head and Neck

Volumn 30, Issue 1, 2008, Pages 111-121

  Ziober, Barry L ^a   Mauk, Michael G ^b   Falls, Erica M ^a   Chen, Zongyuan ^b   Ziober, Amy F ^a   Bau, Haim H ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarkers; Lab on a chip; Microfluidics; Oral cancer; Screening

Indexed keywords

CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER SCREENING; CELL ISOLATION; CELL SELECTION; CHROMOSOME TRANSLOCATION; CYTOLOGY; DIAGNOSTIC TEST; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LAB ON A CHIP; MICROFLUIDICS; MICROSATELLITE INSTABILITY; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL ADHESION MOLECULES; GENE EXPRESSION PROFILING; HUMANS; MASS SCREENING; MICROFLUIDIC ANALYTICAL TECHNIQUES; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOFTWARE; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 38549118424     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20680     Document Type: Review

References (68)

1. Funk GF, Karnell LH, Robinson RA, Zhen WNK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002;24:165-180.
2. Okamoto M, Nishimine M, Kishi M, et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 2002;31:227-233.
3. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:67-76.
4. Ensley JF, Gutkind JS, Jacobs JR, Lippman SM. Head and neck cancer: emerging perspectives. New York: Academic Press; 2003.
5. Shingaki S, Takada M, Sasai K, et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 2003;185:278-284.
6. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002;68:617-621.
7. Mishra M, Mohanty J, Sengupta S, Tripathy S. Epidemiological and clinicopathological study of oral leukoplakia. Indian J Dermatol Venereol Leprol 2005;71:161-165.
8. Sankaranarayanan R. Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India 2005;18:281-284.
9. Sankaranarayanan R, Ramadas K, Thomas G, et al. Trivandrum Oral Cancer Screening Study Group. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomized controlled trial. Lancet 2005;365:1927-1933.
10. Weinberg MA, Estefan DJ. Assessing oral malignancies. Am Fam Physician 2002;65:1379-1384.
11. Greenman J, Homer JJ, Stafford ND. Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 2000;25:9-18.
12. Aps JKM, Van Den Maagdenberg K, Delanghe JR, Martens LC. Flow cytometry as a new method to quantify the cellular content of human saliva and its relation to gingivitis. Clin Chim Acta 2002;321:35-41.
13. Jiang WW, Rosenbaum E, Mambo E, et al. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res 2006;12:1564-1569.
14. Barrera JE, Ai H, Pan Z, Meyers AD, Varella-Garcia M. Malignancy detection by molecular cytogenetics in clinically normal mucosa adjacent to head and neck tumors. Arch Otolaryngol Head Neck Surg 1998;124:847-851.
15. Spafford MF, Koch WM, Reed AL, et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001;7:607-612.
16. Okami K, Imate Y, Hashimoto Y, Kamada T, Takahashi M. Molecular detection of cancer cells in saliva from oral and pharyngeal cancer patients. Tokai J Exp Clin Med 2002;27:85-89.
17. Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2006;3:CD004150.
18. Hu YC, Sidransky D, Ahrendt SA. Molecular detection approaches for smoking associated tumors. Oncogene 2002;21:7289-7297.
19. Partridge M, Phillips E, Francis R, Li SR. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. J Pathol 1999;189:368-377.
20. Sauk JJ, Nikitakis N, Siavash H. Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target. Front Biosci 2005;10:107-118.
21. Nan A, Ghandehari H, Hebert C, et al. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. J Drug Target 2005;13:189-197.
22. Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-128.
23. Armstrong A, Eck SL. EpCAM: a new therapeutic target for an old cancer antigen. Cancer Biol Ther 2003;2:320-326.
24. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004;23:5748-5758.
25. Gronau SS, Schmitt M, Thess B, et al. Trifunctional bispecific antibody-induced tumor cell lysis of squamous cell carcinomas of the upper aerodigestive tract. Head Neck 2005;27:376-382.
26. Yanamoto S, Kawasaki G, Yoshitomi I, Iwamoto T, Hirata K, Mizuno A. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Oncol. In press.
27. Chaubal S, Wollenberg B, Kastenbauer E, Zeidler R. EpCAM - a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. Anticancer Res 1999;19:2237-2242.
28. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer call discovery and calls prediction by gene expression monitoring. Science 1999;286:531-537.
29. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate behavior. Cancer Cell 2002;1:203-209.
30. Ziober AF, Patel KR, Alawi F, et al. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res 2006;12:5960-5971.
31. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
32. Vielba R, Bilbao J, Ispizua A, et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003;113:167-172.
33. Somoza-Martin JM, Garcia-Garcia A, Barros-Angueira F, et al. Gene expression profile in oral squamous cell carcinoma: a pilot study. J Oral Maxillofac Surg 2005;63:786-792.
34. Belbin TJ, Singh B, Smith RV, et al. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131:10-18.
35. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
36. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000;16:906-914.
37. Park NJ, Li Y, Yu T, Brinkman BM, Wong DT. Characterization of RNA in saliva. Clin Chem 2006;52:988-994.
38. Kumar SV, Hurteau GJ, Spivack SD. Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res 2006;12:5033-5039.
39. Burns MA, Mastrangelo CH, Sammarco TS, et al. Microfabricated structures for integrated DNA analysis. Proc Natl Acad Sci U S A 1996;93:5556-5561.
40. Waters LC, Jacobson SC, Kroutchinina N, Khandurina J, Foote RS, Ramsey JM. Microchip device for cell lysis, multiplex PCR amplification, and electrophoretic sizing. Anal Chem 1998;70:158-162.
41. Anderson RC, Su X, Bogdan GJ, Fenton J. A miniaturized integrated device for automated multistep genetic assays. Nucleic Acids Res 2000;28:e60.
42. Auroux P-A, Koc Y, deMello A, Manz A, Day PJR. Miniaturized nucleic acid analysis. Lab Chip 2004;4:534-546.
43. Liu RH, Yang J, Lenigk R, Bonanno J, Grodzinski P. Self-contained, fully integrated, biochip for sample preparation, pCR amplification, and DNA microarray. Anal Chem 2004;76:1824-1831.
44. Lagally ET, Mathies ET. Integrated genetic analysis microsystems. J Phys D Appl Phys 2004;37:R245-R261.
45. Srinivasan V, Pamula K, Fair RB. An integrated digital microfluidic lab-on-a-chip for clinical diagnostis on human physiological fluids. Lab Chip 2004;4:310-315.
46. Lee C-Y, Lee G-B, Lin J-L, Huang F-C, Liao C-S. Integrated microfluidics systems for cell lysis, mixing/pumping and DNA amplification. J Micromech Microeng 2005;15:1215-1223.
47. Klaassen I, Copper MP, Brakenhoff RH, Smeets SJ, Snow GB, Braakhuis BJ. Exfoliated oral cell messenger RNA: suitability for biomarker studies. Cancer Epidemiol Biomarkers Prev 1998;7:469-472.
48. Spivack SD, Hurteau GJ, Jain R, et al. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res 2004;64:6805-6813.
49. El-Naggar AK, Mao L, Staerkel G, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 2001;3:164-170.
50. Rosas SL, Koch W, da Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-942.
51. Mastrangelo CH, Burns MA, Burke DT. Microfabricated devices for genetic diagnostics. Proc IEEE 1998;86:1769-1787.
52. McGlennen RC. Miniaturization technologies for molecular diagnostics. Clin Chem 2001;47:393-402.
53. Verpoorte E. Microfluidic chips for clinical and forensic analysis. Electrophoresis 2002;23:677-712.
54. Ahn CH, Choi JW, Beaucage G, et al. Disposable smart lab on a chip for point-of-care diagnostics. Proc IEEE 2004;92:154-173.
55. Erickson D, Li D. Integrated microfluidic devices. Anal Chim Acta 2004;507:11-26.
56. Beebe DJ, Mensing GA, Walker GM. Physics and applications of microfluidics in biology. Ann Rev Biomed Eng 2002;4:261-286.
57. Verpoorte E, Rooij NF. Microfluidics meets MEMS. Proc IEEE 2003;91:930-953.
58. Stone HA, Stroock AD, Ajdari A. Engineering flows in small devices: microfluidics toward lab-on-a-chip. Ann Rev Fluid Mech 2004;36:381-411.
59. Koltay P, Ducrée J, Zengerle R. Microfluidic platforms. In: Urban G, editor. BioMEMS. New York: Springer; 2006.
60. Roper MG, Easley CJ, Landers JP. Advances in polymerase chain reaction on microfluidic chips. Anal Chem 2005;77:3887-3893.
61. Zhang ,C. Xu J, Ma W, Zheng W. PCR microfluidic devices for DNA amplification. Biotechnol Adv 2006;24:243-284.
62. Sippy N, Luxton R, Lewis RJ, Cowell DC. Rapid electrochemical detection and identification of catalase positive micro-organisms. Biosens Bioelectron 2000;18:741-749.
63. Stoeva SI, Lee JS, Smith JE, Rosen ST, Mirkin CA. Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. J Am Chem Soc 2006;128:8378-8379.
64. Stoeva SI, Lee JS, Thaxton CS, Mirkin CA. Multiplexed DNA detection with biobarcoded nanoparticle probes. Angew Chem Int Ed Engl 2006; 45:3303-3306.
65. Marcus JS, Anderson WF, Quake SR. Microfluidic single-cell mRNA isolation and analysis. Anal Chem 2006;78:3084-3089.
66. Chang YH, Lee GB, Huang FC, Chen YY, Lin JL. Integrated polymerase chain reaction chips utilizing digital microfluidics. Biomed Microdevices 2006;8:215-225.
67. Tsai NC, Sue CY. SU-8 based continuous-flow RT-PCR bio-chips under high-precision temperature control. Biosens Bioelectron 2006;22:313-317.
68. Epstein JR, Leung AP, Lee KH, Walt DR. High density, microsphere-based fiber optic DNA microarray. Biosens Bioelectron 2003;18:541-546.